Novartis highlights key data in patients with hematologic diseases and breast cancer
- Details
- Category: Novartis

Novartis receives FDA approval for Flucelvax®
- Details
- Category: Novartis

Shire and Boston Children's Hospital enter into broad research collaboration
- Details
- Category: Shire

Results from the positive phase III AVAglio study
- Details
- Category: Roche

Bayer's "Perspective on Innovation 2012"
- Details
- Category: Bayer

Sanofi and T1D Exchange to launch worldwide study
- Details
- Category: Sanofi

Bristol-Myers Squibb Foundation's Together on Diabetes™ marks World Diabetes Day
- Details
- Category: Bristol-Myers Squibb

More Pharma News ...
- The largest clinical study of Bayer's Xarelto® (rivaroxaban)
- Boehringer Ingelheim enters strategic collaboration agreement to support Molecular Partner's proprietary pipeline
- Novartis future growth prospects secured by industry-leading pipeline
- Results from the largest known cholesterol survey conducted in the U.S.
- Portola, Bristol-Myers Squibb and Pfizer sign clinical collaboration agreement to study ELIQUIS® and Portola's universal Factor Xa inhibitor antidote PRT4445
- Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D
- Novartis to start construction of new biotechnology facility in Singapore